Cargando...
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
Collectively, hematological malignancies account for the fourth most common malignancy. Myeloma and lymphoma are the most common types of hematological malignancies. Unfortunately, the management of refractory myeloma and lymphoma remains challenging. The discovery of new immunological therapies, na...
Gardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8009535/ https://ncbi.nlm.nih.gov/pubmed/33814917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S242018 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|